{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:15:17Z","timestamp":1782231317569,"version":"3.54.5"},"reference-count":36,"publisher":"Elsevier BV","issue":"42","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.vaccine.2007.08.021","type":"journal-article","created":{"date-parts":[[2007,9,4]],"date-time":"2007-09-04T12:42:51Z","timestamp":1188909771000},"page":"7301-7306","source":"Crossref","is-referenced-by-count":6,"title":["Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity"],"prefix":"10.1016","volume":"25","author":[{"given":"Jim E.","family":"Eyles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy A.","family":"Butcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Titball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2007.08.021_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia pestis\u2014etiologic agent of plague","volume":"10","author":"Perry","year":"1997","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"10.1016\/j.vaccine.2007.08.021_bib2","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1128\/IAI.64.6.2180-2187.1996","article-title":"Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge","volume":"64","author":"Andrews","year":"1996","journal-title":"Infect Immun"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2007.08.021_bib3","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine","volume":"16","author":"Heath","year":"1998","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2007.08.021_bib4","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1128\/IAI.63.8.2854-2858.1995","article-title":"Active Immunisation with Recombinant V-Antigen from Yersinia-pestis protects mice against plague","volume":"63","author":"Leary","year":"1995","journal-title":"Infect Immun"},{"issue":"16","key":"10.1016\/j.vaccine.2007.08.021_bib5","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/0264-410X(95)00090-N","article-title":"A comparison of plague vaccine, Usp and Ev76 vaccine-induced protection against Yersinia-pestis in a murine model","volume":"13","author":"Russell","year":"1995","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2007.08.021_bib6","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1517\/14712598.4.6.965","article-title":"Yersinia pestis (plague) vaccines","volume":"4","author":"Titball","year":"2004","journal-title":"Expert Opin Biol Ther"},{"issue":"4","key":"10.1016\/j.vaccine.2007.08.021_bib7","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1365-2672.2001.01497.x","article-title":"Plague vaccine research and development","volume":"91","author":"Williamson","year":"2001","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.vaccine.2007.08.021_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/bmb\/62.1.163","article-title":"Vaccines against dangerous pathogens","volume":"62","author":"Williamson","year":"2002","journal-title":"Brit Med Bull"},{"issue":"4\u20135","key":"10.1016\/j.vaccine.2007.08.021_bib9","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0264-410X(00)00159-6","article-title":"A single dose sub-unit vaccine protects against pneumonic plague","volume":"19","author":"Williamson","year":"2000","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2007.08.021_bib10","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1128\/JCM.35.11.2826-2833.1997","article-title":"Recent emergence of new variants of Yersinia pestis in Madagascar","volume":"35","author":"Guiyoule","year":"1997","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.021_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3201\/eid0701.010106","article-title":"Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis","volume":"7","author":"Guiyoule","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2007.08.021_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1574-695X.1999.tb01229.x","article-title":"The SCID\/Beige mouse as a model to investigate protection against Yersinia pestis","volume":"23","author":"Green","year":"1999","journal-title":"Fems Immunol Med Microbiol"},{"issue":"11","key":"10.1016\/j.vaccine.2007.08.021_bib13","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1128\/IAI.65.11.4476-4482.1997","article-title":"Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunisation","volume":"65","author":"Hill","year":"1997","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2007.08.021_bib14","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1128\/IAI.62.10.4192-4201.1994","article-title":"Passive-immunity to Yersiniae mediated by anti-recombinant V-antigen and protein a-V-antigen fusion peptide","volume":"62","author":"Motin","year":"1994","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2007.08.021_bib15","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1128\/IAI.71.4.2234-2238.2003","article-title":"Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis","volume":"71","author":"Hill","year":"2003","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2007.08.021_bib16","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1128\/IAI.74.5.3068-3070.2006","article-title":"Administration of antibody to the lung protects mice against pneumonic plague","volume":"74","author":"Hill","year":"2006","journal-title":"Infect Immun"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2007.08.021_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0264-410X(99)00214-5","article-title":"Expression of a recombinant form of the V antigen of Yersinia pestis, using three different expression systems","volume":"18","author":"Carr","year":"1999","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2007.08.021_bib18","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1128\/IAI.65.5.1926-1930.1997","article-title":"Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plague","volume":"65","author":"Titball","year":"1997","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2007.08.021_bib19","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4269\/ajtmh.1997.56.471","article-title":"Protection of mice from fatal bubonic and pneumonic plague by passive immunisation with monoclonal antibodies against the F1 protein of Yersinia pestis","volume":"56","author":"Anderson","year":"1997","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2007.08.021_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1574-695X.2000.tb01426.x","article-title":"Identification of immunodominant epitope of F1 antigen of Yersinia pestis","volume":"27","author":"Sabhnani","year":"2000","journal-title":"Fems Immunol Med Microbiol"},{"issue":"31\u201332","key":"10.1016\/j.vaccine.2007.08.021_bib21","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1016\/j.vaccine.2004.02.049","article-title":"Immunisation against plague by transcutaneous and intradermal application of subunit antigens","volume":"22","author":"Eyles","year":"2004","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2007.08.021_bib22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejpb.2005.04.009","article-title":"Non-invasive pulmonary aerosol delivery in mice by the endotracheal route","volume":"61","author":"Bivas-Benita","year":"2005","journal-title":"Eur J Pharm Biopharm"},{"issue":"10","key":"10.1016\/j.vaccine.2007.08.021_bib23","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0264-410X(96)00303-9","article-title":"A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunised animals against pneumonic plague","volume":"15","author":"Williamson","year":"1997","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2007.08.021_bib24","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0264-410X(97)00249-1","article-title":"Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse","volume":"16","author":"Eyles","year":"1998","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2007.08.021_bib25","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/jac\/37.4.769","article-title":"Doxycycline or ciprofloxacin prophylaxis and therapy against experimental Yersinia pestis infection in mice","volume":"37","author":"Russell","year":"1996","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.vaccine.2007.08.021_bib26","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S1286-4579(00)00355-5","article-title":"Preventing infectious disease with passive immunisation","volume":"2","author":"Zeitlin","year":"2000","journal-title":"Microbes Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.021_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3201\/eid0501.990107","article-title":"Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases","volume":"5","author":"Zeitlin","year":"1999","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2007.08.021_bib28","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3201\/eid0808.010516","article-title":"Passive antibody administration (immediate immunity) as a specific defense against biological weapons","volume":"8","author":"Casadevall","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2007.08.021_bib29","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1128\/IAI.73.11.7304-7310.2005","article-title":"Cell-mediated protection against pulmonary Yersinia pestis infection","volume":"73","author":"Parent","year":"2005","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.021_bib30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2249.1999.00859.x","article-title":"An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model","volume":"116","author":"Williamson","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.08.021_bib31","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/infdis\/175.3.524","article-title":"Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies","volume":"175","author":"vanBinnendijk","year":"1997","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2007.08.021_bib32","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4138::AID-IMMU4138>3.0.CO;2-L","article-title":"Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice","volume":"28","author":"Siegrist","year":"1998","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.08.021_bib33","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1128\/IAI.73.4.2197-2204.2005","article-title":"Yersinia pestis V protein epitopes recognized by CD4 T cells","volume":"73","author":"Parent","year":"2005","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2007.08.021_bib34","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1128\/IAI.67.3.1533-1537.1999","article-title":"Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis","volume":"67","author":"Andrews","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.08.021_bib35","first-page":"5","article-title":"Immunisation of mice with YscF provides protection from Yersinia pestis infections","author":"Matson","year":"2005","journal-title":"Bmc Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.021_bib36","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1128\/IAI.64.1.375-379.1996","article-title":"Invasin production by Yersinia pestis is abolished by insertion of an IS200-like element within the inv gene","volume":"64","author":"Simonet","year":"1996","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07009450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07009450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,26]],"date-time":"2020-04-26T08:25:26Z","timestamp":1587889526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07009450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":36,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0264410X07009450"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.08.021","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}